5. Third primary doses of the COVID-19 vaccine for those who are severely immunosuppressed
Emerging data suggests that some individuals with severely suppressed immune systems will not mount a full immune response to COVID-19 vaccination, and therefore may be less protected than the wider population. People with severe immunosuppression are more likely to be severely ill if they catch COVID-19.
On 1 September 2021, the JCVI advised that individuals aged 12 and over who were severely immunosuppressed at the time of their first or second dose should be offered a third primary dose of the vaccine, as it may increase their protection. This offer is separate to any potential booster programme. A third primary dose is an extra 'top-up' dose for those who may not have generated a full immune response to the first two doses. The JCVI will review whether those identified as severely immunosuppressed require a further booster at a later date, following completion of their 3-dose primary course.
Those with lower levels of immunosuppression, alongside most individuals whose immunosuppression commenced at least two weeks after the second dose of vaccination, do not require a third primary dose at this stage. Initial letters will be issued inviting individuals to a scheduled appointment at community based clinics from week beginning 27 September 2021, with work ongoing with specialist clinicians to identify and invite other severely immunosuppressed patients in due course.
There is a problem
Thanks for your feedback